Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.16% to 10140.70, DAX +0.57% to 25405.34, CAC40 (0.04%) to 8358.76, STOXX 600 +0.21% to 610.95

Jan 12 ,2026

  • Synopsis:

    • European equities closed mostly higher and near the best levels of the session with France, Denmark and Finland edging lower. Basic resources, construction & materials and banks were the best performing sectors whilst travel & leisure, autos and utilities lagged. Follows strong performance last week, with fresh record levels across the region.

    • Markets digesting escalation in US-Fed tensions intensified as federal prosecutors opened a criminal investigation into Fed Chair Powell over his congressional testimony on the central bank's headquarters renovation, which Powell described in a video statement as a pretext for Trump's pressure to cut rates and undermine independence; comes after Trump in December voiced his displeasure at Powell and expressed a desire to fire him.

    • Iran the focus of latest geopolitical headlines after President Trump confirmed US military weighing "strong options" for Tehran as regime intensifies crackdown against large-sale demonstrations. Iran threatened to retaliate against any strike, putting American bases, commercial interest and as well as Israel in its crosshairs. EU ready for new sanctions. Oil spiked following initial headlines before erasing gains as market reassesses whether renewed hostilities would directly impact crude flows from Strait of Hormuz. On Greenland, US Secretary of State Rubio set to meet Danish and Greenlandic ministers on Wednesday to discuss the island's future. European leaders, including those from Denmark, France, Germany, and the UK, have united in support of Denmark and Greenland against renewed US threats

    • In Europe, EZ Sentix investor confidence improved to (1.8) versus (5.0) expected and (6.2) prior. Elsewhere, EU member states approved signature of EU-Mercosur trade agreement on 9-Jan, with von der Leyen to sign deal on 17-Jan. EU and China reahced deal on EV tariffs. ECB's Muller reiterated rates in right place. In the UK, KPMG/REC Dec 2025 Report on Jobs reinforced picture of labor market deterioration.

    • On a reporting calendar that is steadily getting busier, BE Semiconductor Industries (BESI.NA) shares are rallying this morning after posting Q4 numbers whilst - in the UK - Plus500 (PLUS.LN) and IQE FY (IQE.LN) released trading updates; elsewhere, Viridien (VIRI.FP), Cosmo Pharmaceuticals (COPN.SW) and Azimut Holding (AZM.IM) posted prelim numbers, with the latter also guiding FY26. Of note, Barclays (BARC.LN) shares are trading trading lower after Trump called for a one-year 10% cap on credit card interest rates.

    • In M&A news, according to local French press, Eli Lilly (LLY) is reportedly ready to invest €15.0B to acquire Abivax (ABVX.FP), with shares of the latter up +30% at the open; in Italy, local daily Il Messaggero wrote that the Pirelli (PIRC.IM) shareholder pact between Camfin and Sinochem will be dissolved soon. In management news, a slew of CEO changes were announced this morning, including Heineken (HEIA.NA), British Land Co. (BLND.LN) and DFDS (DFDS.DC).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +1.82%, Construct & Mtls +0.86%, Banks +0.56%, Oil & Gas +0.54%, Retail +0.44%, Telecom +0.42%, Technology +0.39%, Financial Svcs +0.34%, Ind Goods & Svcs +0.30%, Persnl & HHold Goods +0.28%

      • Underperformers:

        • Travel & Leisure (1.54%), Autos & Parts (1.22%), Utilities (0.95%), Media (0.59%), Real Estate (0.32%), Insurance (0.23%), Health Care (0.14%), Chemicals +0.06%, Food & Beverage +0.18%

    • Macro:

      • Geopolitics:

        • EU ambassadors' approval of EU-Mercosur deal cleared path for von der Leyen to sign the 25-year-negotiated deal in Paraguay on 17-Jan - Politico, Guardian, LeMonde, Politico

        • Denmark faces critical moment due to Trump's repeated threats over Greenland - Guardian

        • Europe commits to continued military assistance for Ukraine - Semafor

      • Central banks:

        • Criticism grows over ECB's handling of digital euro project - Welt

        • ECB enters its calmest year following five years of turbulence - El Pais

      • UK:

        • UK labor market deteriorated in Dec - KPMG/REC Report

        • Concerns rise over feasibility of full rail nationalization plan - London Times

        • UK competition authority clears all mergers in 2025 under government pressure for pro-growth stance - FT

        • Draft EU agreement includes safeguard against Reform UK election win - Guardian

      • France:

        • Far-right support keeps rising in French public opinion polls - Le Monde

        • Prolonged debates on 2026 budget in French parliament pose risks - Le Parisien

    • Company news:

      • Notable Gainers

        • +42.2% IQE.LN (IQE £0.10, +0.03) -- FY trading update

        • +18.8% FUM.LN (Futura Medical £0.02, -0.00) -- results from WSD4000 early feasibility study

        • +9.7% AMG.NA (AMG Critical Materials €34.74, +3.06) -- Oddo upgrade

        • +9.6% INTRUM.SS (Intrum SEK44.76, +3.91) -- sale of remaining 35% holding of portfolios currently owned in jv with Brocc at c.€215M

        • +7.6% IVA.FP (Inventiva €4.41, +0.31) -- initiated outperform at Leerink Partners

        • +7.3% BESI.NA (BE Semiconductor Industries €162.15, +11.05) -- prelim. Q4 orders

        • +6.3% ITAB.SS (ITAB Shop Concept SEK18.54, +1.10) -- buy recommendation at Dagens Industri

        • +5.5% NANO.LN (Nanoco Group £0.08, -0.00) -- litigation update

        • +5.5% NANO.LN (Nanoco Group £0.08, -0.00) -- files answer and counterclaims to complaint for declaratory judgement originally filed by Shoei in US District Court for Eastern District of Virginia

        • +5.1% NEWA.B.SS (New Wave Group SEK118.50, +5.80) -- Handelsbanken upgrade

        • +5.1% ABVX.FP (Abivax €104.00, +5.00) -- Eli Lilly reportedly ready to invest €15.0B to acquire Abivax - La Lettr

        • +4.3% SCATC.NO (Scatec NOK113.60, +4.70) -- signs PPA

        • +3.8% FCT.IM (Fincantieri €20.24, +0.75) -- €200M order

        • +3.5% UN0.GR (Uniper €35.95, +1.20) -- and AM Green sign long-term offtake agreement for up to 500,000 tons per year of renewable ammonia from India

        • +3.2% VIRI.FP (Viridien €119.80, +3.70) -- prelim. FY revenue

        • +2.8% DFDS.DC (DFDS DKK101.20, +2.75) -- new President & CEO

        • +2.1% BAYN.GR (Bayer AG €39.71, +0.83) -- acquisition of pan-amyloid radiotracers from Attralus

        • +2.0% SGE.LN (Sage Group £11.05, +0.22) -- UBS upgrade

      • Notable Decliners

        • -8.1% SINCH.SS (Sinch SEK28.88, -2.55) -- Morgan Stanley downgrade

        • -7.4% SWON.SW (SoftwareONE Holding CHF8.18, -0.65) -- Morgan Stanley downgrade

        • -6.5% WPP.LN (WPP Group £3.27, -0.23) -- initiated neutral at CITI

        • -6.0% P911.GR (Porsche €44.27, -2.83) -- trading lower; negative comments at Oddo conference cited - headlines only

        • -4.3% NETC.DC (Netcompany Group DKK343.60, -15.60) -- Morgan Stanley downgrade

        • -4.2% CAP.FP (Capgemini €144.45, -6.40) -- Morgan Stanley downgrade

        • -4.1% HEIA.NA (Heineken €67.18, -2.90) -- CEO and Chairman to step down; BNP Paribas Exane downgrade

        • -3.8% BLND.LN (British Land Co. £3.98, -0.16) -- CEO to step down

        • -3.1% ARGX.BB (argenx €671.80, -21.80) -- prelim. Q4 global product net sales

        • -3.0% PNDORA.DC (Pandora DKK571.00, -17.40) -- Nordea downgrade

        • -3.0% TIETO.FH (Tietoevry €18.59, -0.57) -- Morgan Stanley downgrade

        • -2.9% NORBT.NO (Norbit NOK188.40, -5.60) -- initiated hold at DNB Carnegie

        • -2.9% AHT.LN (Ashtead Group £54.32, -1.62) -- BofA downgrade

        • -2.6% TPK.LN (Travis Perkins £6.50, -0.18) -- Stifel downgrade

        • -2.5% MNDI.LN (Mondi £8.96, -0.23) -- Morgan Stanley downgrade

        • -2.5% IG.IM (Italgas €10.06, -0.26) -- announces exchange price per share of €500M green bonds exchangeable

        • -2.4% BARC.LN (Barclays £4.73, -0.12) -- Barclays trading lower; possible sympathy move after Trump called for a one-year 10% cap on credit card interest rate

        • -2.4% BARC.LN (Barclays £4.73, -0.12) -- trading lower; possible sympathy move after Trump called for a one-year 10% cap on credit card interest rates

        • -1.2% WKL.NA (Wolters Kluwer €90.20, -1.06) -- initiated buy at CITI

    • EU companies reporting tomorrow:

      • Earnings:

        • DACHs: Suedzucker (SZU.GR), Agrana Beteiligungs (AGR.AV)

        • France: Vente-Unique.com (ALVU.FP)

      • Trading Update:

        • DACHs: Sika Group (SIKA.SW), Chocoladefabriken Lindt & Spruengli (LISN.SW)

        • Southern Europe: Jeronimo Martins (JMT.PL)

        • UK: Persimmon (PSN.LN), Whitbread (WTB.LN), Grafton Group (GFTU.LN), Integrafin Holdings (IHP.LN), PageGroup (PAGE.LN), Trustpilot Group (TRST.LN), Hunting (HTG.LN), Gym Group (GYM.LN), SIG (SHI.LN)

      • Traffic: DFDS (DFDS.DC)

  • Data:

    • Economics:

      • Eurozone Jan Sentix investor confidence (1.8) vs consensus (5.1), prior (6.2)

      • Switzerland Dec consumer sentiment (30.7) vs consensus (34.0), prior (33.8)

      • Denmark Dec CPI +1.9% y/y vs consensus +2.1%, prior +2.1%

    • Markets:

      • WTI Crude (Feb 26): +$0.23 or +0.39% to $59.35

      • €-$ +0.0045 or +0.39% to 1.1680

      • £-$ +0.0074 or +0.55% to 1.3472

      • €-£ (0.0013) to 0.8671

      • S&P 500 +0.05%

      • Performance year-to-date

        • FTSE 100: +2.11%

        • DAX: +3.74%

        • CAC: +2.57%

        • MIB: +1.75%

        • Stoxx 600: +3.17%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE